$CDNA on NASDAQ
January 09, 2024
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
December 19, 2023
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
November 08, 2023
CareDx Reports Third Quarter 2023 Results
November 02, 2023
CareDx to Report Third Quarter 2023 Financial Results
November 01, 2023
CareDx Announces CEO Transition
October 17, 2023
CareDx Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual Meeting
October 03, 2023
CareDx Issues Statement on Supreme Court Decision Regarding Stanford-Licensed Patents
September 19, 2023
CareDx To Present at the 2023 Cantor Global Healthcare Conference
September 14, 2023
CareDx Advances Global Transplant Patient Care at ESOT Congress 2023
August 31, 2023
CareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 17, 2023
CareDx Hosts Second Annual MEET Digital Health User Conference to Showcase Latest Innovations to Enhance Transplant Patient Care
August 11, 2023
CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection
August 08, 2023
CareDx Reports Second Quarter 2023 Results
August 07, 2023
CareDx Announces District Court Judge Bars Natera from Falsely Advertising and Overstating the Scientific Performance of its Prospera Transplant Test
August 03, 2023
CareDx to Report Second Quarter 2023 Financial Results
August 02, 2023
CareDx’s HeartCare Multimodality Service Receives Medicare Coverage for Heart Transplant Surveillance
July 17, 2023
CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant Test
July 11, 2023
CareDx’s AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring
June 01, 2023
CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress
June 01, 2023
CareDx to Participate in Upcoming Investor Conferences
May 16, 2023
CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum
May 10, 2023
CareDx Reports First Quarter 2023 Results
May 08, 2023
CareDx to Report First Quarter 2023 Financial Results
April 25, 2023
CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference
April 19, 2023
CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation
April 06, 2023
National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community
March 23, 2023
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association
March 07, 2023
The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance
March 06, 2023
CareDx Update Regarding Raymond James & Associates’ Conference
March 06, 2023
CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
March 03, 2023
CareDx Comments on MolDX Publication of New Billing and Coding Article
March 01, 2023
CareDx Key Supporter of the National Kidney Foundation’s Annual Kidney Patient Summit
February 27, 2023
CareDx Reports Fourth Quarter and Full Year 2022 Results
February 22, 2023
CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting
February 21, 2023
CareDx to Report Fourth Quarter and Full Year 2022 Financial Results
February 16, 2023
CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings
January 26, 2023
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice
January 11, 2023
CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium
January 09, 2023
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
December 21, 2022
New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients
December 06, 2022
CareDx Announces $50 Million Stock Repurchase Program
December 01, 2022
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance
November 11, 2022
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
November 04, 2022
CareDx To Participate in Upcoming Investor Conferences
November 03, 2022
CareDx Reports Third Quarter 2022 Results
November 02, 2022
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
November 01, 2022
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
October 27, 2022
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
October 26, 2022
CareDx to Report Third Quarter 2022 Financial Results
October 26, 2022
CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients
- No Recent Filings Found.
